-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 19, according to foreign media reports, Johnson & Johnson, AbbVie's Allergan, Teva Pharmaceuticals and Endo will face a virtual trial because they are accused of downplaying the risk of opioid addiction in order to promote this Sales of powerful painkillers.
Several major county and city governments in California filed lawsuits against the four companies, demanding damages of up to 50 billion U.
S.
The allegations against opioid manufacturers are part of thousands of lawsuits brought by state and local governments to address the problems caused by opioid overdose.
This is the second largest opioid case that has entered trial after Oklahoma successfully prosecuted Johnson & Johnson in 2019.
Johnson & Johnson is not the only company in Oklahoma that has been sentenced to financial damages.
In addition to the company's role in the opioid crisis, Johnson & Johnson will also face more than 25,000 charges, alleging that its talc products cause ovarian cancer or mesothelioma due to asbestos contamination.